313 related articles for article (PubMed ID: 17990588)
1. Septated pericarditis associated with Kawasaki disease: a brief case report.
Sonçaği A; Devrim I; Karagöz T; Dilber E; Celiker A; Ozen S; Seçmeer G
Turk J Pediatr; 2007; 49(3):312-4. PubMed ID: 17990588
[TBL] [Abstract][Full Text] [Related]
2. Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease.
Liu FF; Liu HH; Qiu Z; Wang JJ; Samadli S; Wu Y; Wu YF; Xu Y; Luo HH; Chen WX; Zhang DD; Hu P
Eur J Clin Invest; 2020 Apr; 50(4):e13210. PubMed ID: 32061097
[TBL] [Abstract][Full Text] [Related]
3. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
Williams K
J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
[TBL] [Abstract][Full Text] [Related]
4. Kawasaki disease.
Sundel RP
Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
[TBL] [Abstract][Full Text] [Related]
5. [Kawasaki disease in children--9 years experience].
Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Tang Y; Yan W; Sun L; Xu Q; Ding Y; Lv H
Clin Rheumatol; 2018 Jul; 37(7):1945-1951. PubMed ID: 29330741
[TBL] [Abstract][Full Text] [Related]
7. Multisystem Imaging Manifestations of Kawasaki Disease.
Tsujioka Y; Handa A; Nishimura G; Miura M; Yokoyama K; Sato K; Handa H; Jinzaki M; Nosaka S; Kono T
Radiographics; 2022; 42(1):268-288. PubMed ID: 34826255
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
Pilania RK; Jindal AK; Johnson N; Prithvi A; Vignesh P; Suri D; Rawat A; Gupta A; Singh S
Rheumatology (Oxford); 2021 Jul; 60(7):3413-3419. PubMed ID: 33221920
[TBL] [Abstract][Full Text] [Related]
9. Images in cardiovascular medicine. Giant coronary artery aneurysms in Kawasaki disease.
Lilje C; Joyce JJ
Circulation; 2005 Jun; 111(24):e440. PubMed ID: 15967855
[No Abstract] [Full Text] [Related]
10. Two Distinct Cases of Adult-onset Kawasaki Disease.
Onoki T; Metoki T; Iwasawa S; Kawano K; Kimura M; Kure S; Ota C
Intern Med; 2022 Dec; 61(23):3525-3529. PubMed ID: 35466164
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC; Corsello G; Prinzi E; Cimaz R
Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
[TBL] [Abstract][Full Text] [Related]
12. Kawasaki disease: part II. Complications and treatment.
Bayers S; Shulman ST; Paller AS
J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report.
Yu X; Liu X; Wang Y; Lu N; Wang M; Sun L
Medicine (Baltimore); 2019 Feb; 98(7):e14395. PubMed ID: 30762741
[TBL] [Abstract][Full Text] [Related]
14. [The role of immunosuppressive agents in Kawasaki disease: a discussion of two cases].
Peyre M; Laroche C; Etchecopar C; Brosset P
Arch Pediatr; 2013 Jul; 20(7):748-53. PubMed ID: 23693156
[TBL] [Abstract][Full Text] [Related]
15. A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.
Sadeghi P; Izadi A; Mojtahedi SY; Khedmat L; Jafari M; Afshin A; Yarahmadi P; Hosseinali Beigi E
BMC Infect Dis; 2021 Apr; 21(1):368. PubMed ID: 33874899
[TBL] [Abstract][Full Text] [Related]
16. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
[TBL] [Abstract][Full Text] [Related]
17. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
Abushaban L; Salama A; Uthaman B; Kumar A; Selvan J
Int J Cardiol; 1999 Apr; 69(1):71-6. PubMed ID: 10362375
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
Durongpisitkul K; Sangtawesin C; Khongphatthanayopthin A; Panamonta M; Sopontammarak S; Sittiwangkul R; Pongpanich B
Asian Pac J Allergy Immunol; 2006 Mar; 24(1):27-32. PubMed ID: 16913186
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki disease and juvenile systemic lupus erythematosus.
Diniz JC; Almeida RT; Aikawa NE; Sallum AM; Sakane PT; Silva CA
Lupus; 2012 Jan; 21(1):89-92. PubMed ID: 21959137
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
Mori M; Imagawa T; Hara R; Kikuchi M; Hara T; Nozawa T; Miyamae T; Yokota S
J Rheumatol; 2012 Apr; 39(4):864-7. PubMed ID: 22337241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
